ArticleScientific reports2025
Enhancing tumor deepfake detection in MRI scans using adversarial feature fusion ensembles.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- FairGen: preference-aligned diffusion for demographically equitable medical image synthesis.NPJ digital medicine · 2026Article
- A Multiphase CT-Based Integrated Deep Learning Framework for Rectal Cancer Detection, Segmentation, and Staging: Performance Comparison with Radiologist Assessment.Journal of imaging · 2026Article
- Topic-Modeling Guided Semantic Clustering for Enhancing CNN-Based Image Classification Using Scale-Invariant Feature Transform and Block Gabor Filtering.Journal of imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The proliferation of AI-generated medical deepfakes, such as tumor insertions or removals in diagnostic scans, threatens patient safety and healthcare integrity. Existing detection methods often lack robustness against adversarial attacks or fail to integrate multimodal feature representations. To address these gaps, we propose AFFETDS (Adversarial Feature Fusion Enhanced Tumor Detection System), a novel ensemble framework combining adversarial training, feature fusion, and weighted voting. AFFETDS leverages adversarial attack methods (PGD, FGSM) to harden the model, fuses high-level ResNet50 features with handcrafted HOG descriptors, and employs an SVM-based ensemble classifier. Evaluated on a curated dataset of 1378 MRI scans (774 real, 604 manipulated) from TCIA and ADNI repositories, AFFETDS achieves state-of-the-art performance with 91.5% accuracy, 90.7% precision, and 91.2% recall, outperforming baseline models (SVM: 86.2%, CNN: 88.4%). The framework's ROC-AUC (0.80) and calibrated confidence scores demonstrate superior generalization across diverse imaging conditions. The ability of combining the adversarial techniques with multimodal feature fusion, our proposed AFFETDS framework improves the detection of subtle tumor manipulations, presenting an important safeguard to maintain the authenticity of medical images. The findings of research work underscore the urgent need of proactive defenses against growing deepfake threats in healthcare applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.